A prospective external validation of the urine spermine risk score for high-grade prostate cancer detection in two urology units in Hong Kong

被引：0
|
作者：
Chiu, P. K. [1 ]
Mok, A. [1 ]
Leung, C. H. [1 ]
Wong, Y. P. [1 ]
Guo, H. D. [1 ]
Fung, Y. H. [2 ]
Tse, R. T. [1 ]
Tsoi, T. H. [2 ]
Teoh, J. Y. [1 ]
Lo, K. L. [1 ]
Ng, C. F. [1 ]
Wong, K. L. [2 ]
机构：
[1] Chinese Univ Hong Kong, Dept Surg, SH Ho Urol Ctr, Hong Kong, Peoples R China
[2] Hong Kong Baptist Univ, Dept Chem, Hong Kong, Peoples R China
来源：
BJU INTERNATIONAL | 2023年 / 131卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
OP. 2-12
引用
下载
收藏
页码：11 / 12
页数：2
相关论文
共 50 条
  • [41] VALIDATION OF A NOVEL NON-INVASIVE URINE EXOSOME GENE EXPRESSION ASSAY TO PREDICT HIGH-GRADE PROSTATE CANCER IN PATIENTS UNDERGOING INITIAL BIOPSY WITH AN EQUIVOCAL PSA
    McKiernan, James
    Donovan, Michael
    O'Neill, Vince
    Bentink, Stefan
    Noerholm, Mikkel
    Belzer, Susan
    Skog, Johan
    Partin, Alan
    Andriole, Gerald
    Brown, Gordon
    Cochran, James
    Wei, John
    Thompson, Ian
    Carroll, Peter
    JOURNAL OF UROLOGY, 2015, 193 (04): : E495 - E496
  • [42] Prostate cancer lesion detection, volume quantification and high-grade cancer differentiation using cancer risk maps derived from multiparametric MRI with histopathology as the reference standard
    Gibbons, Matthew
    Simko, Jeffry P.
    Carroll, Peter R.
    Noworolski, Susan M.
    MAGNETIC RESONANCE IMAGING, 2023, 99 : 48 - 57
  • [43] Prospective validation of the ROL system in substaging pT1 high-grade bladder cancer: A confirmatory progression risk analysis to ease decision making
    Valeri, M.
    Contieri, R.
    Fasulo, V
    Cieri, M.
    Elefante, G. M.
    De Carlo, C.
    Saitta, C.
    Gobbo, A.
    Avolio, P. P.
    Lazzeri, M.
    Taverna, G.
    Terracciano, L. M.
    Hurle, R.
    Colombo, P.
    EUROPEAN UROLOGY, 2022, 81 : S362 - S362
  • [44] PROSPECTIVE VALIDATION OF THE ROL SYSTEM IN SUBSTAGING PT1 HIGH-GRADE BLADDER CANCER: A CONFIRMATORY PROGRESSION RISK ANALYSIS TO EASE DECISION MAKING
    Valeri, Marina
    Contieri, Roberto
    Fasulo, Vittorio
    Cieri, Miriam
    Elefante, Grazia M.
    Lazzeri, Massimo
    Taverna, Gianluigi
    Varese, Castellanza
    Terracciano, Luigi M.
    Hurle, Rodolfo
    Colombo, Piergiuseppe
    JOURNAL OF UROLOGY, 2022, 207 (05): : E391 - E391
  • [45] Risk of prostate cancer after detection of isolated high-grade prostatic intraepithelial neoplasia (HGPIN) on extended core needle biopsy: A UK hospital experience
    Singh P.B.
    Nicholson C.M.
    Ragavan N.
    Blades R.A.
    Martin F.L.
    Matanhelia S.S.
    BMC Urology, 9 (1)
  • [46] Re: Pathologic Characteristics of Cancers Detected in the Prostate Cancer Prevention Trial: Implications for Prostate Cancer Detection and Chemoprevention Re: Finasteride Does Not Increase the Risk of High-Grade Prostate Cancer: A Bias-Adjusted Modeling Approach
    Schellhammer, Paul F.
    EUROPEAN UROLOGY, 2009, 55 (02) : 522 - 523
  • [47] Long-term aspirin use and the risk of total, high-grade, regionally advanced and lethal prostate cancer in a prospective cohort of health professionals, 1988-2006
    Dhillon, Preet K.
    Kenfield, Stacey A.
    Stampfer, Meir J.
    Giovannucci, Edward L.
    INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (10) : 2444 - 2452
  • [48] Early detection of high-grade prostate cancer using digital rectal examination (DRE) in men with a prostate-specific antigen level of <2.5 ng/mL and the risk of death
    Hattangadi, Jona A.
    Chen, Ming-Hui
    D'Amico, Anthony V.
    BJU INTERNATIONAL, 2012, 110 (11) : 1636 - 1641
  • [49] Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2-10 ng/ml at Initial Biopsy
    McKiernan, James
    Donovan, Michael J.
    Margolis, Eric
    Partin, Alan
    Carter, Ballentine
    Brown, Gordon
    Torkler, Phillipp
    Noerholm, Mikkel
    Skog, Johan
    Shore, Neal
    Andriole, Gerry
    Thompson, Ian
    Carroll, Peter
    EUROPEAN UROLOGY, 2018, 74 (06) : 731 - 738
  • [50] Re: A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2-10 ng/ml at Initial Biopsy
    Urabe, Fumihiko
    Ochiya, Takahiro
    Egawa, Shin
    EUROPEAN UROLOGY, 2019, 76 (02) : 254 - 255
12345